Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

• click to rate

  Posted by Two Blokes May 22, 2025 - Filed in Stock - 5 views
  
  - Vigil's shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent value right of $2.00 per share in cash following the first commercial sale of VG-3927 -